Breast neoplasm
Information
- Disease name
- Breast neoplasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04388384 | Active, not recruiting | Real-life Pan-HER-blockade With Neratinib | July 2, 2020 | January 2025 | |
| NCT03935282 | Active, not recruiting | N/A | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors | October 1, 2020 | March 7, 2025 |
| NCT01432002 | Active, not recruiting | FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer | November 2007 | December 2023 | |
| NCT05169567 | Active, not recruiting | Phase 3 | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer | March 11, 2022 | February 16, 2026 |
| NCT03269981 | Active, not recruiting | N/A | Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer | April 1, 2017 | December 30, 2029 |
| NCT04660929 | Active, not recruiting | Phase 1 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | February 2, 2021 | December 31, 2024 |
| NCT05633680 | Active, not recruiting | Circulating Tumor Cells Screen for Breast Cancer | February 20, 2020 | June 20, 2023 | |
| NCT03141437 | Active, not recruiting | N/A | Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer | April 23, 2017 | April 30, 2025 |
| NCT01758445 | Active, not recruiting | Phase 2 | Proton Radiation for Stage II/III Breast Cancer | February 2013 | January 2030 |
| NCT02992782 | Active, not recruiting | N/A | Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management | June 1, 2017 | November 30, 2024 |
| NCT05441943 | Active, not recruiting | N/A | Lymphaticovenous Anastomosis as Treatment for Lymphedema | May 11, 2022 | December 31, 2026 |
| NCT04489173 | Active, not recruiting | Phase 2 | TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer | September 25, 2020 | December 2024 |
| NCT05364450 | Active, not recruiting | N/A | Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | July 17, 2021 | August 1, 2024 |
| NCT02983071 | Active, not recruiting | Phase 1/Phase 2 | G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer | January 2017 | October 2023 |
| NCT02284919 | Active, not recruiting | Phase 1 | [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer | November 2014 | November 2024 |
| NCT04893421 | Active, not recruiting | N/A | Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization | May 16, 2021 | June 30, 2024 |
| NCT02950259 | Active, not recruiting | Phase 1 | Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | February 9, 2017 | May 2024 |
| NCT02608216 | Active, not recruiting | Phase 1 | [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer | November 2015 | November 2024 |
| NCT02409316 | Active, not recruiting | Phase 2 | [18F]FES PET/CT in Endocrine Refractory Breast Cancer | May 2015 | December 2024 |
| NCT00550771 | Completed | Phase 2 | Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) | July 16, 2007 | August 23, 2010 |
| NCT00573495 | Completed | Phase 1 | Multipeptide Vaccine for Advanced Breast Cancer | November 2007 | February 2013 |
| NCT00583739 | Completed | Phase 2 | Yoga to Reduce Cancer Fatigue | August 2007 | October 2008 |
| NCT00591747 | Completed | N/A | Strength Training for Older Breast Cancer Survivors | November 2005 | June 2011 |
| NCT00659906 | Completed | N/A | Optimizing Body Composition & Health After Breast Cancer | January 2006 | January 2009 |
| NCT00687440 | Completed | Phase 2 | A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) | July 15, 2005 | October 24, 2008 |
| NCT00736333 | Completed | A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED) | November 2006 | June 2010 | |
| NCT00779129 | Completed | Phase 2 | A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948) | March 2003 | August 2007 |
| NCT00821288 | Completed | N/A | Post-treatment Care of Breast Cancer Survivors | July 2007 | May 2013 |
| NCT00831545 | Completed | Phase 2 | Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) | December 1, 2000 | October 20, 2006 |
| NCT01061359 | Completed | Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer | January 1999 | October 2009 | |
| NCT01199393 | Completed | Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer | August 2010 | May 2015 | |
| NCT01466972 | Completed | Phase 2 | Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib | April 27, 2012 | October 2, 2019 |
| NCT01621295 | Completed | Assessing the Patient Experience in Cancer Care | May 2012 | September 2015 | |
| NCT01707121 | Completed | The Impact of Physical Activity on the Outcome of Surgery | December 2012 | November 2015 | |
| NCT01859936 | Completed | Phase 4 | Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment | February 2008 | April 2013 |
| NCT02056080 | Completed | Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib | January 2013 | January 2014 | |
| NCT02061085 | Completed | Phase 2 | Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment | July 2013 | December 2015 |
| NCT02316561 | Completed | N/A | Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer | October 2014 | April 2018 |
| NCT04440995 | Completed | N/A | The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction | July 8, 2020 | October 10, 2021 |
| NCT00001440 | Completed | Phase 1 | Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy | July 1995 | January 2002 |
| NCT00001496 | Completed | Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer | January 1996 | November 2001 | |
| NCT00001504 | Completed | Phase 1 | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients | May 1996 | January 2002 |
| NCT00001507 | Completed | Phase 1 | Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer | July 12, 1996 | June 20, 2014 |
| NCT00001837 | Completed | Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients | November 1998 | October 2005 | |
| NCT00001898 | Completed | Microarray Analysis for Human Genetic Disease | June 29, 1999 | May 20, 2008 | |
| NCT00005908 | Completed | Phase 2 | Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | June 2000 | January 2008 |
| NCT00034281 | Completed | Phase 1 | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | June 2002 | September 2003 |
| NCT00107016 | Completed | Phase 2 | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women | March 2005 | April 2007 |
| NCT00194727 | Completed | Phase 2 | Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer | May 2002 | March 2011 |
| NCT00194740 | Completed | Phase 2 | Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer | November 1997 | June 2007 |
| NCT00194753 | Completed | Phase 2 | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 | December 2001 | March 2011 |
| NCT00201435 | Completed | Phase 2/Phase 3 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | March 2005 | May 2008 |
| NCT00270894 | Completed | Phase 2 | Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients | November 2005 | August 2011 |
| NCT00295529 | Completed | N/A | GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians | April 2005 | June 2007 |
| NCT00313248 | Completed | Phase 2 | Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer | April 2006 | November 2008 |
| NCT00463788 | Completed | Phase 2 | Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer | June 2007 | February 2011 |
| NCT00530868 | Completed | Phase 2 | Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer | October 8, 2007 | March 31, 2022 |
| NCT02513472 | Completed | Phase 1/Phase 2 | Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) | August 28, 2015 | April 6, 2021 |
| NCT02561468 | Completed | N/A | The Preemptive Analgesic Efficacy of Nefopam | April 2015 | January 2016 |
| NCT02609724 | Completed | N/A | Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL | January 2016 | September 2020 |
| NCT02627976 | Completed | N/A | Breast Edema Compression Vest | February 2016 | January 2018 |
| NCT02800317 | Completed | N/A | RISAS Procedure in Node Positive Breast Cancer Following NAC | March 30, 2017 | December 3, 2021 |
| NCT02957981 | Completed | N/A | The Genetic Education for Men Trial: Web-Based Education vs. Standard Care | October 1, 2018 | April 1, 2022 |
| NCT02970682 | Completed | Phase 2 | SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer | October 2016 | March 2019 |
| NCT03013881 | Completed | Phase 1 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers | March 5, 2018 | April 2, 2019 |
| NCT03066947 | Completed | Phase 1/Phase 2 | SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer | May 5, 2017 | November 22, 2018 |
| NCT03069742 | Completed | N/A | Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting | November 2016 | August 2022 |
| NCT03124095 | Completed | N/A | Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer | September 2016 | December 31, 2017 |
| NCT03202472 | Completed | N/A | Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery | August 3, 2017 | February 1, 2019 |
| NCT03273426 | Completed | N/A | Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy. | September 8, 2016 | February 1, 2018 |
| NCT03280836 | Completed | N/A | Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | August 3, 2017 | December 21, 2020 |
| NCT03330717 | Completed | N/A | Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery | November 15, 2017 | December 31, 2019 |
| NCT03351075 | Completed | N/A | Effectiveness of a Modern Educational Intervention in Breast Cancer Patients | November 27, 2017 | September 5, 2021 |
| NCT03455270 | Completed | Phase 1 | G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer | May 9, 2018 | September 29, 2022 |
| NCT03546673 | Completed | N/A | Health Benefits of Expressive Writing: Study One | July 2009 | October 2011 |
| NCT03651921 | Completed | N/A | Testing of the Cancer Thriving and Surviving Breast Cancer Program | December 12, 2017 | August 15, 2019 |
| NCT03687749 | Completed | Presentation of First Time Attenders at Lymphedema Clinics | February 1, 2017 | December 31, 2020 | |
| NCT03761420 | Completed | Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome | August 1, 2019 | April 1, 2021 | |
| NCT03868514 | Completed | Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) | July 4, 2019 | November 15, 2023 | |
| NCT03874598 | Completed | N/A | Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer | June 12, 2019 | February 19, 2020 |
| NCT04002284 | Completed | Phase 2 | Anlotinib in Metastatic HER2 Negative Breast Cancer | July 12, 2018 | March 15, 2020 |
| NCT04227613 | Completed | Aspects of Breast-conserving Surgery | January 1, 2019 | June 30, 2022 | |
| NCT00001250 | Completed | Phase 2 | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial | December 1989 | October 2002 |
| NCT04444882 | Completed | Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care | June 1, 2021 | January 28, 2022 | |
| NCT04640220 | Completed | N/A | Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors | October 26, 2020 | December 31, 2021 |
| NCT04767464 | Completed | N/A | Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups | March 1, 2021 | November 7, 2023 |
| NCT04824599 | Completed | N/A | Regional Anesthesia and Partial Mastectomy | February 19, 2021 | May 1, 2022 |
| NCT05267171 | Completed | N/A | Project Breast47: Effect of an Educational Intervention | January 15, 2022 | June 26, 2022 |
| NCT05576545 | Completed | N/A | Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment | September 18, 2020 | August 15, 2022 |
| NCT05604677 | Completed | Factor Influencing Breast Surgery Type Decision-Making | June 15, 2022 | August 19, 2022 | |
| NCT03328026 | Enrolling by invitation | Phase 1/Phase 2 | Combination Study of SV-BR-1-GM With Retifanlimab | March 16, 2018 | June 30, 2024 |
| NCT06294574 | Not yet recruiting | N/A | Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction | December 2024 | December 2026 |
| NCT05862610 | Not yet recruiting | Phase 2 | The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC | July 30, 2023 | June 30, 2027 |
| NCT06056414 | Not yet recruiting | N/A | Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation | October 2, 2023 | October 9, 2023 |
| NCT05949983 | Not yet recruiting | N/A | Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer | January 1, 2024 | January 1, 2026 |
| NCT06268665 | Not yet recruiting | Phase 2 | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | February 28, 2024 | June 2027 |
| NCT06090747 | Recruiting | N/A | Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. | March 9, 2023 | December 31, 2028 |
| NCT05582499 | Recruiting | Phase 1/Phase 2 | Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy | November 1, 2022 | September 2025 |
| NCT05309265 | Recruiting | N/A | Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study | May 9, 2022 | May 2024 |
| NCT03445637 | Recruiting | Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® | February 8, 2018 | August 8, 2025 | |
| NCT05594095 | Recruiting | Phase 2 | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | December 30, 2022 | December 1, 2026 |
| NCT06255808 | Recruiting | Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor | October 5, 2022 | January 5, 2025 | |
| NCT01766297 | Recruiting | Phase 2 | Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer | February 2013 | January 2033 |
| NCT05427071 | Recruiting | N/A | Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy | October 15, 2020 | December 31, 2028 |
| NCT03740893 | Recruiting | Phase 2 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer | October 15, 2019 | December 2025 |
| NCT05505643 | Recruiting | N/A | Cryoablation vs Lumpectomy in T1 Breast Cancers | April 3, 2024 | October 31, 2031 |
| NCT05868187 | Recruiting | N/A | CanRestoreFunction Cancer-related Fatigue ( CRF ) | March 1, 2023 | April 30, 2024 |
| NCT05889988 | Recruiting | A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients | June 12, 2023 | June 2025 | |
| NCT05020860 | Recruiting | Phase 2 | Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | April 18, 2023 | November 2029 |
| NCT06212440 | Recruiting | N/A | Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy | May 4, 2021 | June 30, 2026 |
| NCT04799535 | Recruiting | Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring | September 1, 2019 | November 29, 2028 | |
| NCT06058650 | Recruiting | N/A | Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities | August 26, 2021 | August 26, 2026 |
| NCT06100068 | Recruiting | N/A | HOBBIT 3: Mental Exercises and Temporal Alteration | November 27, 2023 | September 1, 2024 |
| NCT06072612 | Recruiting | Phase 3 | Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. | December 5, 2023 | December 2025 |
| NCT06075810 | Recruiting | Phase 1 | A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | November 9, 2023 | October 31, 2024 |
| NCT04652609 | Recruiting | N/A | Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program | January 1, 2021 | January 1, 2027 |
| NCT04583124 | Recruiting | N/A | Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO) | September 30, 2021 | September 30, 2025 |
| NCT02978716 | Terminated | Phase 2 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) | February 2, 2017 | February 28, 2020 |
| NCT03295552 | Terminated | Phase 2 | Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC | November 15, 2017 | June 1, 2021 |
| NCT03321903 | Terminated | EPR Tumor Oximetry With CE India Ink | August 30, 2017 | October 27, 2019 | |
| NCT00005655 | Terminated | Phase 1 | Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer | April 28, 2000 | March 2, 2017 |
| NCT03740984 | Terminated | N/A | Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy | February 1, 2018 | November 1, 2021 |
| NCT01233947 | Terminated | Phase 2 | Study of AFP464 +/- Faslodex in ER + Breast Cancer | May 2011 | August 2012 |
| NCT04305236 | Terminated | Phase 2 | Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer | July 23, 2020 | February 16, 2022 |
| NCT00779285 | Terminated | Phase 4 | Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED) | February 2006 | August 2006 |
| NCT02602067 | Terminated | Phase 1 | 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients | November 2015 | April 30, 2017 |
| NCT00771381 | Terminated | Phase 2 | A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer | November 28, 2008 | February 4, 2019 |
| NCT00249301 | Terminated | Phase 1 | A Study of MLN8054 in Patients With Advanced Solid Tumors | October 2005 | |
| NCT03008031 | Terminated | N/A | Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM) | January 2017 | April 2020 |
| NCT00638963 | Terminated | Phase 2 | Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2) | October 2, 2008 | June 30, 2010 |
| NCT00251095 | Terminated | Phase 3 | Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | September 2005 | September 2007 |
| NCT01755130 | Terminated | N/A | Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer | May 13, 2014 | June 2, 2021 |
| NCT03220178 | Terminated | Phase 4 | Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy | July 24, 2017 | December 7, 2021 |
| NCT01596530 | Terminated | Phase 1 | Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment | June 2012 | May 2013 |
| NCT02370082 | Unknown status | N/A | SAVI SCOUT Clinical Evaluation Study | February 2015 | August 2015 |
| NCT03024463 | Unknown status | The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients | August 1, 2017 | August 1, 2019 | |
| NCT02455141 | Unknown status | Phase 3 | Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer | July 2015 | December 2023 |
| NCT01221870 | Unknown status | Phase 2 | Tesetaxel as First-line Therapy for Metastatic Breast Cancer | November 2010 | January 2013 |
| NCT04083027 | Unknown status | Non-mass Enhancement in Breast MRI | March 2020 | September 2021 | |
| NCT03024580 | Unknown status | Phase 2 | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | March 6, 2017 | September 2020 |
| NCT03939598 | Unknown status | Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study | March 27, 2019 | December 31, 2020 | |
| NCT04861220 | Unknown status | N/A | Surgical Pre-habilitation in Breast Cancer. | January 1, 2022 | December 30, 2023 |
| NCT03606369 | Unknown status | Phase 2/Phase 3 | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. | November 5, 2015 | December 31, 2020 |
| NCT02913573 | Unknown status | Phase 2 | Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction | September 2016 | March 2019 |
| NCT02914197 | Unknown status | N/A | Giving Information on the Risks and Limitations of Mammography Screening (GIRLS) | November 20, 2017 | November 2019 |
| NCT02318615 | Unknown status | N/A | Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention | December 2015 | August 2020 |
| NCT03881605 | Unknown status | N/A | MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC | November 8, 2018 | June 2021 |
| NCT05050890 | Unknown status | Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia | August 5, 2020 | February 28, 2022 | |
| NCT02065960 | Unknown status | Phase 1 | Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer | February 2014 | June 2020 |
| NCT03625635 | Unknown status | N/A | Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment | September 14, 2015 | August 2019 |
| NCT03000192 | Unknown status | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | August 2016 | September 2021 | |
| NCT03275727 | Unknown status | Phase 2/Phase 3 | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer | February 2018 | December 2019 |
| NCT03021200 | Unknown status | N/A | Laser Fluorescence in Cancer Surgical Treatment | July 12, 2016 | December 10, 2020 |
| NCT04644848 | Unknown status | N/A | Ultrasonographic Axillary Localization | December 15, 2020 | April 2022 |
| NCT02610920 | Withdrawn | Early Phase 1 | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection | December 2015 | January 2018 |
| NCT02372305 | Withdrawn | Phase 4 | Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery | March 2016 | December 21, 2017 |
| NCT01015521 | Withdrawn | Phase 2 | Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer | April 2010 | |
| NCT03426254 | Withdrawn | Phase 1 | Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors | November 10, 2022 | January 10, 2024 |
| NCT03266562 | Withdrawn | N/A | Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography | September 1, 2018 | April 30, 2019 |
| NCT02432118 | Withdrawn | N/A | Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy | May 2015 | May 2016 |